A

Aura Biosciences
D

AURA

8.94000
USD
0.06
(0.68%)
Market Closed
Volume
2,584
EPS
-2
Div Yield
-
P/E
-5
Market Cap
446,566,106
OverviewSignalsIdeasNews
Related Instruments
    A
    AYX
    0
    (0%)
    0.000000 USD
    C
    CHGG
    -0.01000
    (-0.58%)
    1.71000 USD
    CRWD
    CRWD
    -7.64
    (-2.22%)
    336.77 USD
    D
    DOCU
    -1.240
    (-1.54%)
    79.120 USD
    F
    FSLY
    -0.71000
    (-9.99%)
    6.40000 USD
    P
    PINS
    -1.130
    (-3.85%)
    28.240 USD
    SHOP
    SHOP
    -0.580
    (-0.53%)
    108.510 USD
    T
    TWLO
    -0.600
    (-0.62%)
    96.540 USD
    UBER
    UBER
    1.810
    (2.53%)
    71.545 USD
    Z
    ZM
    -1.500
    (-1.82%)
    81.120 USD
    More
News

Title: Aura Biosciences

Sector: Healthcare
Industry: Biotechnology
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.